Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
LSD
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
==Interactions== {{See also|Psychedelic drug#Interactions|Trip killer#Serotonergic psychedelic antidotes}} Some psychedelics, including LSD, are [[drug metabolism|metabolized]] by the [[cytochrome P450]] [[enzyme]] [[CYP2D6]]. Concurrent use of [[selective serotonin reuptake inhibitor]]s (SSRIs), some of which are [[potency (pharmacology)|potent]] [[enzyme inhibitor|inhibitor]]s of CYP2D6, with LSD may heighten the risk of [[serotonin syndrome]].<ref name="drug-interaction"/>{{rp|145}} Chronic usage of SSRIs, [[tricyclic antidepressant]]s (TCAs), and [[monoamine oxidase inhibitor]]s (MAOIs) is believed to diminish the subjective effects of psychedelics, likely due to [[5-HT2A receptor|5-HT<sub>2A</sub> receptor]] [[receptor downregulation|downregulation or desensitization]] induced by elevated [[serotonin]] levels.<ref name="PassieHalpernStrichtenoth2008" /><ref name="drug-interaction"/>{{rp|145}} Contrary to the preceding notions however, a clinical study found that administration of LSD to people taking [[paroxetine]], an SSRI and strong CYP2D6 inhibitor, increased LSD exposure by about 1.5-fold, was well-tolerated, and did not modify the pleasant subjective effects or physiological effects of LSD, whereas negative effects of LSD, including "bad drug effect", [[anxiety]], and [[nausea]], were reduced.<ref name="BeckerHumbert-DrozMueller2025">{{cite journal | vauthors = Becker AM, Humbert-Droz M, Mueller L, Jelušić A, Tolev A, Straumann I, Avedisian I, Erne L, Thomann J, Luethi D, Grünblatt E, Meyer Zu Schwabedissen H, Liechti ME | title = Acute Effects and Pharmacokinetics of LSD after Paroxetine or Placebo Pre-Administration in a Randomized, Double-Blind, Cross-Over Phase I Trial | journal = Clin Pharmacol Ther | volume = | issue = | pages = | date = February 2025 | pmid = 40022427 | doi = 10.1002/cpt.3618 | url = | doi-access = free }}</ref> Similarly, a clinical study with LSD found that LSD levels were 75% higher in people with non-functional CYP2D6 ([[poor metabolizer]]s) compared to those with functional CYP2D6.<ref name="HalmanKongSarris2024">{{Cite journal |vauthors=Halman A, Kong G, Sarris J, Perkins D |date=January 2024 |title=Drug-drug interactions involving classic psychedelics: A systematic review |journal=J Psychopharmacol |volume=38 |issue=1 |pages=3–18 |doi=10.1177/02698811231211219 |pmc=10851641 |pmid=37982394}}</ref><ref name="VizeliStraumannHolze2021">{{cite journal | vauthors = Vizeli P, Straumann I, Holze F, Schmid Y, Dolder PC, Liechti ME | title = Genetic influence of CYP2D6 on pharmacokinetics and acute subjective effects of LSD in a pooled analysis | journal = Sci Rep | volume = 11 | issue = 1 | pages = 10851 | date = May 2021 | pmid = 34035391 | pmc = 8149637 | doi = 10.1038/s41598-021-90343-y | bibcode = 2021NatSR..1110851V | url = }}</ref> In contrast to certain other psychedelics, MAOIs do not inhibit the [[drug metabolism|metabolism]] of or potentiate the effects of LSD and instead reduce its effects.<ref name="PassieHalpernStrichtenoth2008" /> Interactions between psychedelics and [[antipsychotic]]s or [[anticonvulsant]]s are not well-documented; however, co-use with [[mood stabilizer]]s like [[lithium (medication)|lithium]] may induce [[seizure]]s and [[dissociative disorder|dissociative effects]], particularly in individuals with [[bipolar disorder]].<ref name="drug-interaction"/>{{rp|146}}<ref>{{cite journal |journal=Drug and Alcohol Dependence |volume=239 |at=109586 |vauthors=Simonsson O, Goldberg SB, Chambers R, Osika W, Long DM, Hendricks PS |date=1 October 2022 |pmid=35981469 |pmc=9627432 |title=Prevalence and associations of classic psychedelic-related seizures in a population-based sample |doi=10.1016/j.drugalcdep.2022.109586}}</ref><ref>{{cite journal |year=1967 |journal=Western Journal of Medicine |vauthors=Fisher D, Ungerleider J |pmid=4962683 |pmc=1502729 |volume=106 |issue=3 |pages=201–211 |title=Grand mal seizures following ingestion of LSD}}</ref> Lithium notably intensifies LSD reactions, potentially leading to acute comatose states when combined.<ref name="PassieHalpernStrichtenoth2008" />
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)